Catalysts? I suppose "potential catalysts" takes the pressure off, since potential leaves a lot of wiggle room
BUP interim very unlikely to move price - not controlled trial.So if 15 of 16 clear up a great deal, might help a smidge
Start of P 2b expected no boost
Start of K ovarian p2 - overdue and expected no boost
K top line data- you are kidding, right? NO boost, data known. This is like expecting a boost from an academic journal article, another poster favorite boost(not)
We are let with B-OM. Any chance of interim update 2016? Who knows. I would bet 2017.
In other words, there is little going on in the near term in terms of actual catalysts. Check back in 6-12 months.